A third of people across the UK are overdue their cervical cancer screening, while in parts of England some are at greater risk of the disease than others due to a low uptake for the preventive vaccine, experts have warned.
Since the coronavirus pandemic, cervical screening attendance rates for women and other people with cervixes have been steadily declining, from 72.2% in 2020 to 68.4% in 2024, NHS England data shows.
